Niko Gene Arya

 

Representative of authoritative companies in the field of vaccine, drug and food additive productions.

Offering the best quality

Best service and technical knowledge

Nationwide distribution of drugs, vaccines and biological materials.

Compliance with all standards of maintenance and distribution

With comprehensive coverage of distribution across the country

Nikan Pakhsh . . . Beh Afarin

Nobivac® Tricat Trio

Nobivac® Tricat Trio

Injectable live vaccine for cats

SKU Nik-3003-en Categories ,

Description

Nobivac Tricat Trio

Injectable live vaccine for cats containing attenuated feline panleucopaenia virus (MW-1), feline herpesvirus and feline calicivirus.

Live vaccine for the active immunization of cats to reduce clinical signs caused by an infection with feline calicivirus (FCV) and feline herpes virus type 1 (FHV1) and to prevent clinical signs, virus excretion and leucopenia caused by feline panleucopenia virus (FPLV).

Live vaccine containing per dose of 1 ml reconstituted vaccine:

  • live attenuated feline calicivirus, strain F9: ≥104.6 PFU;
  • live attenuated feline herpes virus type 1, strain G2620A: ≥105.2 PFU;
    live attenuated feline panleucopenia virus, strain MW-1: ≥104.3 CCID50

 Active immunisation of cats to reduce clinical signs caused by an infection with feline calicivirus (FCV) and feline herpes virus type 1 (FHV1) and to prevent clinical signs, virus excretion and leucopenia caused by feline panleucopenia virus (FPLV).

Active Ingredients

A live attenuated freeze dried vaccine containing feline herpes virus type 1 (rhinotracheitis), feline calicivirus and feline panleucopaenia virus (MW-1).

Indications
For the active immunisation of cats against feline panleucopaenia virus (FPLV), feline herpes virus (FHV) and feline calicivirus (FCV). Vaccination will reduce clinical signs caused by infection with FHV and FCV; reduce replication of FCV, and prevent shedding of FPLV.

  • The duration of immunity is 3 years for the FCV, FHV and FPLV components, as confirmed by challenge study.

Dosage
The contents of one vial of reconstituted vaccine should be injected subcutaneously. Reconstitute immediately prior to use by addition of one vial of Nobivac Diluent.

For an initial vaccination, two doses are required, at an interval of 3 to 4 weeks. The first inoculation is given from the age of 8-9 weeks and the second inoculation from the age of 12 weeks. If earlier vaccination if desirable or necessary, vaccination is appropriate from 6 weeks of age onwards, but should be followed by the normal vaccination scheme at 8-9 and 12 weeks of age.

Revaccination
A single dose. Recommended revaccination following initial programme:

  • FCV, FHV and FPLV revaccinate three-yearly.
  • For cats exposed to high-risk environments, annual revaccination should be considered.

Packaging Quantities

Cardboard boxes containing 10 or 50 single dose vials. The diluent may be packed together with the vaccine or separately. Not all pack sizes may be marketed.

MSD Product